Piyush Agarwal to Male
This is a "connection" page, showing publications Piyush Agarwal has written about Male.
Connection Strength
0.507
-
Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors. Urol Oncol. 2025 Jan; 43(1):62.e7-62.e13.
Score: 0.048
-
The impact of metabolic syndrome on short term radical cystectomy complications. Urol Oncol. 2024 Dec; 42(12):450.e23-450.e28.
Score: 0.047
-
Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience. Diagn Interv Radiol. 2018 Sep; 24(5):316-320.
Score: 0.032
-
Bilateral Ureteroenteric Strictures: A Case of the "Reverse 7". Urology. 2018 Aug; 118:e3-e4.
Score: 0.031
-
Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database. Int Urol Nephrol. 2018 Feb; 50(2):257-262.
Score: 0.030
-
Effect of metabolic syndrome on pathologic features of prostate cancer. Urol Oncol. 2013 Oct; 31(7):1054-9.
Score: 0.021
-
Editorial comment. J Urol. 2011 Apr; 185(4):1261.
Score: 0.019
-
Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol. 2011 May; 59(5):684-98.
Score: 0.019
-
Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen. J Urol. 2010 Jan; 183(1):118-24.
Score: 0.017
-
Role of PSA velocity in predicting pathologic upgrade for Gleason 6 prostate cancer. Urol Oncol. 2011 Jul-Aug; 29(4):372-7.
Score: 0.017
-
Vattikuti Institute prostatectomy: technical modifications in 2009. Eur Urol. 2009 Jul; 56(1):89-96.
Score: 0.016
-
Testicular and paratesticular neoplasms in prepubertal males. J Urol. 2006 Sep; 176(3):875-81.
Score: 0.014
-
Retractile testis--is it really a normal variant? J Urol. 2006 Apr; 175(4):1496-9.
Score: 0.013
-
Testosterone replacement therapy after primary treatment for prostate cancer. J Urol. 2005 Feb; 173(2):533-6.
Score: 0.012
-
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. J Clin Oncol. 2024 Sep 01; 42(25):3033-3046.
Score: 0.012
-
Utilization and Timing of Cystoscopy for Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2024 Jun; 188:80-86.
Score: 0.012
-
Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis. Urol Oncol. 2024 May; 42(5):121-132.
Score: 0.012
-
Incidence of Preoperative Antibiotic Use and Its Association with Postoperative Infectious Complications after Radical Cystectomy. Urology. 2022 06; 164:169-177.
Score: 0.010
-
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. J Clin Oncol. 2020 11 01; 38(31):3672-3684.
Score: 0.009
-
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Lancet Oncol. 2020 08; 21(8):1099-1109.
Score: 0.009
-
Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study. AJR Am J Roentgenol. 2020 01; 214(1):105-113.
Score: 0.009
-
Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer. J Immunol. 2019 06 15; 202(12):3458-3467.
Score: 0.008
-
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer. World J Urol. 2019 Jan; 37(1):51-60.
Score: 0.008
-
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. Clin Epigenetics. 2018; 10:19.
Score: 0.008
-
The Sunshine Act and oncology: Lessons learned from urology. Semin Oncol. 2017 08; 44(4):265-266.
Score: 0.007
-
Advances in medical imaging for the diagnosis and management of common genitourinary cancers. Urol Oncol. 2017 07; 35(7):473-491.
Score: 0.007
-
Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations. Am J Surg Pathol. 2015 Nov; 39(11):1488-92.
Score: 0.006
-
Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol. 2015 Apr; 33(4):167.e13-20.
Score: 0.006
-
Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review. BJU Int. 2014 May; 113(5b):E28-33.
Score: 0.006
-
Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2014 Feb; 65(2):340-7.
Score: 0.006
-
The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. Urol Oncol. 2014 Jan; 32(1):29.e13-20.
Score: 0.005
-
Reply from authors re: Manfred P. Wirth, Johannes Huber. What really matters is rarely measured: outcome of routine care and patient-reported outcomes. Eur Urol 2013;64:58-9: robot-assisted versus open radical cystectomy: beating a dead horse. Eur Urol. 2013 Jul; 64(1):60-1.
Score: 0.005
-
Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC). BJU Int. 2013 Jun; 111(7):1075-80.
Score: 0.005
-
Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2013 Jul; 64(1):52-7.
Score: 0.005
-
Disparities in access to care at high-volume institutions for uro-oncologic procedures. Cancer. 2012 Sep 15; 118(18):4421-6.
Score: 0.005
-
Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology. 2009 Jan; 73(1):147-52.
Score: 0.004
-
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008 Jan 01; 26(1):121-6.
Score: 0.004
-
Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era. J Urol. 2004 Apr; 171(4):1525-8.
Score: 0.003